Letter: Oral sodium cromoglycate in gastrointestinal allergy.
D000284:Administration, Oral; D000328:Adult; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000627:therapeutic use*; D003967:Diarrhea / Q000209:etiology / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D005260:Female; D005396:Fish Products / Q000009:adverse effects; D005512:Food Hypersensitivity / Q000209:etiology / Q000517:prevention & control*; D005638:Fruit / Q000009:adverse effects; D006801:Humans; D010919:Placebos; D012964:Sodium / Q000008:administration & dosage / Q000627:therapeutic use*; D014581:Urticaria / Q000209:etiology / Q000517:prevention & control; D014839:Vomiting / Q000209:etiology / Q000517:prevention & control
D010919:Placebos; D012964:Sodium; D004205:Cromolyn Sodium